ArticleJournal of translational medicine2023

GPRC5D as a promising therapeutic target in EGFR-wild and immuno-cold non-small cell lung cancer.

Jie Mei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.